Production (Stage)
Emmaus Life Sciences, Inc.
EMMA
$0.017
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -26.91% | -39.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -26.91% | -39.91% | |||
| Cost of Revenue | -27.18% | -21.57% | |||
| Gross Profit | -26.89% | -41.33% | |||
| SG&A Expenses | -12.28% | -17.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.03% | -17.35% | |||
| Operating Income | -75.94% | -167.84% | |||
| Income Before Tax | -33.52% | -195.40% | |||
| Income Tax Expenses | -33.33% | 700.00% | |||
| Earnings from Continuing Operations | -33.30% | -195.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.30% | -195.68% | |||
| EBIT | -75.94% | -167.84% | |||
| EBITDA | -76.63% | -166.83% | |||
| EPS Basic | -33.21% | -195.80% | |||
| Normalized Basic EPS | -24.71% | -194.97% | |||
| EPS Diluted | -14.06% | -385.71% | |||
| Normalized Diluted EPS | -24.71% | -342.86% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | -60.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||